Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non‐Hodgkin Large B‐Cell Lymphoma: A Comparative Study of Cell‐Free DNA and Formalin‐Fixed Paraffin‐Embedded Tissue
International Journal of Laboratory Hematology · 2025
DOI: 10.1111/ijlh.14454 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Laboratory Hematology, 2025. Verfasst von Gayaththri Vimalathas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Mutation, Lymphoma, Large B-Cell, Diffuse, Circulating Tumor DNA, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danish Cancer Society, Dagmar Marshall's Foundation, Arvid Nilsson's Foundation.
Abstract (Originalsprache)
Introduction
Formalin‐fixed paraffin‐embedded (FFPE) tumor biopsy is the current mainstay of genotyping, but is limited by its invasiveness and tumor heterogeneity. Plasma cell‐free DNA (cfDNA) constitutes a minimally invasive alternative that may better capture tumor‐derived profiles from circulating tumor DNA (ctDNA). This study compares the performance and genomic concordance of cfDNA and FFPE tumor DNA in aggressive non‐Hodgkin large B‐cell lymphoma.
Methods
Paired diagnostic FFPE tissue and plasma samples from 15 patients were sequenced with a custom 53‐gene panel.
Results
Detection thresholds were empirically guided at 1% variant allele frequency (VAF) for cfDNA and 10% for unpaired FFPE DNA. The median number of cfDNA variants was 6 (interquartile range (IQR): 2–11) versus 63 (IQR: 15–250) in FFPE DNA at 1% VAF. Collectively, 102 somatic variants were shared between cfDNA and FFPE DNA with a median of 5 (range: 0–23). cfDNA showed a five‐fold lower median VAF for shared variants than FFPE DNA (7% vs. 36%, p < 0.0001). Eighty percent of patients harbored at least one cfDNA variant. A maximum cfDNA recall rate of 83% was observed at FFPE DNA VAF > 50%. COSMIC database overlap was twice as high for cfDNA compared to FFPE DNA (22% vs. 11%) at 10% VAF. Conclusion cfDNA has superior specificity for somatic mutation detection but lower sensitivity than FFPE DNA. Modest concordance was demonstrated between the two compartments. Our results support a complementary role of ctDNA in mutational profiling at a 1% VAF threshold in a pragmatic and clinically applicable setup.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
- Haematology-Pathology Research Laboratory, Research Unit for Haematology and Research Unit for Pathology, University of Southern Denmark and Odense University Hospital, Odense, Denmark.
- Department of Pathology, Odense University Hospital, Odense, Denmark.
- Department of Haematology, Odense University Hospital, Odense, Denmark.
- CITCO, Centre for Cellular Immunotherapy of Haematological Cancer Odense, Odense University Hospital, Odense, Denmark.
- OPEN, Odense Patient Data Explorative Network, Odense University Hospital, Odense, Denmark.
ORCID-Profile: Gayaththri Vimalathas, Oriane Cédile, Michael Boe Møller, Charlotte Guldborg Nyvold, Marcus Høy Hansen, Thomas Stauffer Larsen
Förderung
- Danish Cancer Society
- Dagmar Marshall's Foundation
- Arvid Nilsson's Foundation
- The Vissing Foundation
- The Research Council of Odense University Hospital
- Region of Southern Denmark
- Kræftens Bekæmpelse
- Dagmar Marshalls Fond
Zitieren
APA
Vimalathas, G., Cédile, O., Kjeldsen, M. L. G., Thomassen, M., Møller, M. B., Nyvold, C. G., Hansen, M. H., & Larsen, T. S. (2025). Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non‐Hodgkin Large B‐Cell Lymphoma: A Comparative Study of Cell‐Free DNA and Formalin‐Fixed Paraffin‐Embedded Tissue. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14454
Vancouver
Vimalathas G, Cédile O, Kjeldsen MLG, Thomassen M, Møller MB, Nyvold CG, et al. Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non‐Hodgkin Large B‐Cell Lymphoma: A Comparative Study of Cell‐Free DNA and Formalin‐Fixed Paraffin‐Embedded Tissue. International Journal of Laboratory Hematology. 2025. doi:10.1111/ijlh.14454
BibTeX
@article{Vimalathas2025,
author = {Vimalathas, Gayaththri and Cédile, Oriane and Kjeldsen, Marie Louise Grube and Thomassen, Mads and Møller, Michael Boe and Nyvold, Charlotte Guldborg and Hansen, Marcus Høy and Larsen, Thomas Stauffer},
title = {Liquid Biopsy for Enhanced Specificity in Identifying Somatic Mutations in Aggressive Non‐Hodgkin Large B‐Cell Lymphoma: A Comparative Study of Cell‐Free DNA and Formalin‐Fixed Paraffin‐Embedded Tissue},
journal = {International Journal of Laboratory Hematology},
year = {2025},
doi = {10.1111/ijlh.14454}
}
EUVIMED